IBIO · iBio, Inc.
AI read · Bad for IBIO
The AI's read
The notice puts iBio's Nasdaq listing at risk if it cannot meet the share-price rule. Trading continues for now, and the company has 180 calendar days to comply. An extra 180 days may be available if iBio meets other listing rules, but delisting remains possible.